(Q39531759)

English

Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile

scientific article published on 16 June 2011

Statements

Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile (English)
Ken Chi Lik Lee
Joyce Wei Wei Chang
Melvin Chi Yeh Ng
Anders Poulsen
Kanda Sangthongpitag
Hwee Hoon Khng
Jeanette M Wood
Brian W Dymock
Ethirajulu Kantharaj

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit